Inpatient cases
|
N (% of total)
|
40,386 (10%)
|
16,772 (4%)
|
42,789 (11%)
|
59,508 (15%)
|
241,827 (60%)
|
401,282
|
Susceptible isolates (pre-2008 MIC)
|
32,963 (82%)
|
14,284 (85%)
|
38,329 (90%)
|
52,804 (89%)
|
215,160 (89%)
|
353,543
|
Susceptible isolates (post-2008 MIC)
|
36,799 (91%)
|
15,251 (91%)
|
40,877 (96%)
|
56,559 (95%)
|
231,704 (96%)
|
381,190
|
PCN resistant isolates (pre-2008 MIC)*
|
14,375 (36%)
|
3,522 (21%)
|
8,130 (19%)
|
12,497 (21%)
|
58,038 (24%)
|
96,562
|
PCN resistant isolates (post-2008 MIC)
|
4,846 (12%)
|
1,174 (7%)
|
1,711 (4%)
|
2,975 (5%)
|
12,901 (5%)
|
23,607
|
ERY resistant isolates
|
10,821 (26%)
|
3,250 (19%)
|
7,296 (17%)
|
10,811 (18%)
|
48,754 (20%)
|
80,932
|
FQ resistant isolates
|
404 (1%)
|
168 (1%)
|
428 (1%)
|
595 (1%)
|
2,616 (1%)
|
4,211
|
Multiply resistant isolates (pre-2008 MIC)
|
8,562 (21%)
|
2,084 (12%)
|
4,927 (12%)
|
7,603 (13%)
|
36,375 (15%)
|
59,551
|
Multiply resistant isolates (post-2008 MIC)
|
2,926 (7%)
|
716 (4%)
|
1,095 (3%)
|
1,893 (3%)
|
8,115 (3%)
|
14,745
|
Outpatient cases
|
N (% of total)
|
119,613(26%)
|
88,810 (19%)
|
116,427 (25%)
|
78,154 (17%)
|
61,519 (13%)
|
464,523
|
Susceptible isolates (pre-2008 MIC)
|
97,791 (82%)
|
72,608 (82%)
|
101,297 (87%)
|
67,216 (86%)
|
53,524 (87%)
|
392,436
|
Susceptible isolates (post-2008 MIC)
|
106,974 (89%)
|
79,427 (89%)
|
112,860 (97%)
|
74,729 (96%)
|
59,630 (97%)
|
433,620
|
PCN resistant isolates (pre-2008 MIC)
|
44,257 (37%)
|
32,860 (37%)
|
43,078 (37%)
|
28,917 (37%)
|
22,762 (37%)
|
171,873
|
PCN resistant isolates (post-2008 MIC)
|
14,354 (12%)
|
10,657 (12%)
|
9,314 (8%)
|
7,034 (9%)
|
4,922 (8%)
|
46,281
|
ERY resistant isolates
|
37,728 (32%)
|
28,012 (32%)
|
33,532 (29%)
|
22,509 (29%)
|
17,718 (29%)
|
139,499
|
FQ resistant isolates
|
1,196 (1%)
|
888 (1%)
|
1,164 (1%)
|
782 (1%)
|
681 (1%)
|
4,711
|
Multiply resistant isolates (pre-2008 MIC)
|
31,147 (26%)
|
23,126 (26%)
|
28,595 (25%)
|
19,195 (25%)
|
15,141 (25%)
|
117,204
|
Multiply resistant isolates (post-2008 MIC)
|
10,634 (9%)
|
7,895 (9%)
|
6,615 (6%)
|
4,968 (6%)
|
3,550 (6%)
|
33,662
|